Cure8 news brief
If you had bowel surgery for Crohn’s disease and develop postoperative anastomotic bleeding, this study suggests endoscopic treatment can stop bleeding in most patients and may avoid another operation. Patients who need large blood transfusions initially appear more likely to rebleed and may need closer follow-up.
Adults with Crohn’s disease who are post–bowel surgery, gastroenterologists/endoscopists, surgical teams, and clinicians managing postoperative IBD complications.
This report summarizes a multicenter retrospective series of 21 Crohn’s disease patients who had postoperative anastomotic bleeding treated endoscopically between 2021 and 2025.
The authors report 100% initial onsite hemostasis with endoscopic therapy and no procedure-related perforations or anastomotic separations; 9 patients (42.9%) had recurrent bleeding during 1-year follow-up. Need for blood transfusion and higher transfusion volume were associated with higher rebleeding risk.
The article suggests that using endoscopy as the first-line treatment for anastomotic bleeding can avoid reoperation in many patients, and that endoscopic hemostasis appeared safe in this cohort, including after prior resections.
It also highlights that patients who required larger transfusion volumes at presentation were more likely to rebleed and may need closer monitoring or repeat intervention. Limitations to
Early evidence from a small retrospective multicenter series; not a randomized trial. The report focuses on technical success and short-term safety but is limited by sample size and potential selection bias. The original clinical report linked in the article has full methods and data for review.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Small-bowel Crohn's disease often causes strictures and fistulas and typically needs more imaging and procedural care than colonic disease, so patients and clinicians should be aware of its distinct risks and treatment...
This study suggests surgery can help heal severe, noncontiguous (metastatic) skin manifestations of Crohn’s disease when medical therapy alone isn’t enough. It highlights that realistic healing may take many months and...
Surgical technique after ileocolic resection may influence how likely Crohn’s disease is to come back near the anastomosis.
